Free Trial

Integral Ad Science (NASDAQ:IAS) Posts Quarterly Earnings Results

Integral Ad Science logo with Business Services background

Integral Ad Science (NASDAQ:IAS - Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.02, Zacks reports. The company had revenue of $134.07 million for the quarter, compared to analyst estimates of $129.20 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science updated its Q2 2025 guidance to EPS and its FY 2025 guidance to EPS.

Integral Ad Science Stock Performance

Shares of Integral Ad Science stock traded up $0.05 during trading on Friday, reaching $8.09. The company's stock had a trading volume of 1,990,029 shares, compared to its average volume of 1,032,019. The company has a 50-day moving average price of $7.67 and a two-hundred day moving average price of $9.62. Integral Ad Science has a fifty-two week low of $6.26 and a fifty-two week high of $13.62. The firm has a market cap of $1.33 billion, a PE ratio of 40.45, a P/E/G ratio of 1.06 and a beta of 1.55. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Wall Street Analyst Weigh In

A number of brokerages recently commented on IAS. Truist Financial boosted their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a research note on Monday, March 3rd. Scotiabank initiated coverage on Integral Ad Science in a research report on Friday, February 28th. They set a "sector perform" rating and a $12.00 price objective for the company. Benchmark reissued a "hold" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Robert W. Baird restated a "neutral" rating and set a $9.00 target price (down previously from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Finally, Oppenheimer reaffirmed an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $13.55.

Check Out Our Latest Stock Analysis on IAS

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 8,547 shares of the stock in a transaction that occurred on Monday, April 7th. The stock was sold at an average price of $6.85, for a total transaction of $58,546.95. Following the completion of the sale, the chief executive officer now directly owns 341,271 shares of the company's stock, valued at approximately $2,337,706.35. This trade represents a 2.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 86,222 shares of company stock worth $636,252 in the last 90 days. Company insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On Integral Ad Science

Large investors have recently modified their holdings of the stock. Royal Bank of Canada increased its stake in Integral Ad Science by 219.6% in the 1st quarter. Royal Bank of Canada now owns 55,941 shares of the company's stock valued at $451,000 after buying an additional 38,439 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Integral Ad Science by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,326 shares of the company's stock valued at $349,000 after acquiring an additional 1,807 shares in the last quarter. Finally, Caxton Associates LLP acquired a new position in shares of Integral Ad Science during the first quarter worth about $282,000. Hedge funds and other institutional investors own 95.78% of the company's stock.

About Integral Ad Science

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

See Also

Earnings History for Integral Ad Science (NASDAQ:IAS)

Should You Invest $1,000 in Integral Ad Science Right Now?

Before you consider Integral Ad Science, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.

While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines